Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Apr 29 to 30, 2027 · next Apr 29
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,434,760 | Prolinamide derivatives as thrombin inhibitors, preparation method and application thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,456,405 | Nitric oxide-releasing prodrug molecule of substituted quinazolines In force · From the USPTO record | In force | From the USPTO record | |
| US 10,793,536 | Vortioxetine pamoic acid salt and crystal form thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,801,239 | Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor In force · From the USPTO record | In force | From the USPTO record | |
| US 11,197,850 | Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor In force · From the USPTO record | In force | From the USPTO record | |
| US 12,209,141 | Dipeptide compounds and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,398,141 | JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicine In force · From the USPTO record | In force | From the USPTO record | |
| US 12,473,298 | Amide compounds, preparation method therefor, and use thereof in the medical field In force · From the USPTO record | In force | From the USPTO record | |
| US 12,606,566 | SUBSTITUTED CYCLOPENTA[4,5]PYRROLO[1,2-a]PYRAZINES AS BRUTON'S TYROSINE KINASE INHIBITORS In force · High confidence | In force | High confidence | |
| US 12,595,267 | Preparation Method for Amide Compound and Application Thereof in Field of Medicine In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 1 patent in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned